Taro Shareholders Defend Securities Fraud Complaint
Shareholders of Taro Pharmaceutical Industries Ltd. have urged a court to ignore the drug company's motion to toss a securities fraud class action, saying its complaint detailed a fraud that "emanated...To view the full article, register now.
Already a subscriber? Click here to view full article